ATE292978T1 - Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält - Google Patents

Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält

Info

Publication number
ATE292978T1
ATE292978T1 AT01958190T AT01958190T ATE292978T1 AT E292978 T1 ATE292978 T1 AT E292978T1 AT 01958190 T AT01958190 T AT 01958190T AT 01958190 T AT01958190 T AT 01958190T AT E292978 T1 ATE292978 T1 AT E292978T1
Authority
AT
Austria
Prior art keywords
nitrogen oxide
precursor
metabolism
composition containing
iron complexing
Prior art date
Application number
AT01958190T
Other languages
English (en)
Inventor
Bernard Dugas
Original Assignee
Isocell S A
Bernard Dugas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isocell S A, Bernard Dugas filed Critical Isocell S A
Application granted granted Critical
Publication of ATE292978T1 publication Critical patent/ATE292978T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
AT01958190T 2000-07-27 2001-07-27 Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält ATE292978T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0009883A FR2812200B1 (fr) 2000-07-27 2000-07-27 Composition contenant une proteine complexant le fer et un precurseur du metabolisme du monoxyde d'azote et/ou un donneur chimique de monoxyde d'azote ; et utilisations
PCT/FR2001/002469 WO2002009740A1 (fr) 2000-07-27 2001-07-27 Composition contenant une proteine complexant le fer et un precurseur du metabolisme du monoxyde d'azote et/ou un donneur chimique de monoxyde d'azote et utilisations

Publications (1)

Publication Number Publication Date
ATE292978T1 true ATE292978T1 (de) 2005-04-15

Family

ID=8852998

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01958190T ATE292978T1 (de) 2000-07-27 2001-07-27 Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält

Country Status (8)

Country Link
US (1) US6984624B2 (de)
EP (1) EP1303296B1 (de)
JP (1) JP2004520264A (de)
AT (1) ATE292978T1 (de)
AU (1) AU2001279922A1 (de)
DE (1) DE60110084D1 (de)
FR (1) FR2812200B1 (de)
WO (1) WO2002009740A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10215315A1 (de) * 2002-04-05 2003-11-20 Aventis Behring Gmbh Intellect Human-Transferrin zur Behandlung der Anaemia of Chronic Disease (ACD) und des funktionellen Eisenmangels
DK1675501T3 (da) 2003-09-12 2013-11-18 Or Nim Medical Ltd Ikke-invasiv optisk monitorering af et område af interesse
EP1589283B1 (de) * 2004-04-23 2006-08-16 Abb Research Ltd. Modell und Regelung eines Müllverbrennungsverfahrens
MX2007004036A (es) * 2004-10-08 2007-05-24 Unilever Nv Complejo de hierro para uso en el tratamiento y/o prevencion de trastornos nutricionales.
WO2006106805A1 (ja) * 2005-03-30 2006-10-12 Kyowa Hakko Kogyo Co., Ltd. 物質の保存安定性向上方法
WO2009102677A1 (en) * 2008-02-11 2009-08-20 Tabatchnick Fine Foods, Inc. A nutritionally enhanced therapeutic preventative food supplement and method of making same
JP5022454B2 (ja) * 2008-02-14 2012-09-12 森永乳業株式会社 卵巣機能改善剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2149338T3 (es) * 1993-11-02 2000-11-01 Us Health Utilizacion de compuestos que liberan oxido nitrico para la fabricacion de un medicamento destinado al tratamiento de lesiones por reperfusion isquemica.
US5827729A (en) * 1996-04-23 1998-10-27 Advanced Tissue Sciences Diffusion gradient bioreactor and extracorporeal liver device using a three-dimensional liver tissue
JP2002515893A (ja) * 1997-02-03 2002-05-28 ファーミング インテレクチュアル プロパティ ビーブイ ヒトラクトフェリンおよびその改変体の有用な特性

Also Published As

Publication number Publication date
FR2812200B1 (fr) 2003-01-03
DE60110084D1 (de) 2005-05-19
EP1303296B1 (de) 2005-04-13
JP2004520264A (ja) 2004-07-08
US20040033945A1 (en) 2004-02-19
EP1303296A1 (de) 2003-04-23
AU2001279922A1 (en) 2002-02-13
WO2002009740A1 (fr) 2002-02-07
FR2812200A1 (fr) 2002-02-01
US6984624B2 (en) 2006-01-10

Similar Documents

Publication Publication Date Title
WO2007035757A3 (en) Composition and method for treating iron deficiency anemia
ZA878952B (en) Metal complex-containing pharmaceutical agents
NO20015991D0 (no) Bisykliske polyaminoacid-metallkomplekser, fremgangsmåter for fremstilling av disse og anvendelse i medisinsk billeddannelse
MXPA03006055A (es) Nuevos compuestos de n-fenilpirrolbisfosfano y sus complejos de metal.
HK1135333A1 (en) Method of using diketopiperazines and composition containing them
NO954440D0 (no) 2 pyridylmetylenpolyazamakrocyklo-fosfonsyrer, komplekser og derivater derav, for anvendelse som kontrastmidler
NO954441L (no) Tricyklopolyazamakrocyklofosfonsyrer, komplekser og derivater derav for anvendelse som kontrastmidler
MY136095A (en) Use of human anti-ctla-4 antibodies for treatment of cancer
AU2054097A (en) Polyazamacrocyclofluoromonoalkylphosphonic acids, and their complexes, for use as contrast agents
ATE292978T1 (de) Zusammensetzung, welche ein eisenkomplexierendes protein und einen vorläufer im stoffwechsel von stickstoffoxid oder einen stickstoffoxid donor enthält
ATE143266T1 (de) Komplexe und chelate des azithromycins als antiulcus-mittel
DE69907926D1 (de) 1,2,4-triazol-3-thion verbindungen
CA2481593A1 (en) Biologically stable liquid composition of fviii, of vwf or of fviii/vwf complex of human origin
DK1107795T3 (da) Thiomolybdat associeret med mindst ét carbohydrat og dets anvendelse til forebyggelse eller behandling af sygdomme kendetegnet ved aberrerende vascularisation, såsom cancer, maculadegeneration af våd type, rheumatoid arthritis
WO2003027122A3 (en) Lanthanide binding tags
TW200637603A (en) Oral treatment compositions containing anti-adhesion agent, antibacterial agent and incompatible compound
TR199901782T2 (xx) Migren tedavisi i�in ibuprofen ve domperidon ihtiva eden farmas�tik bile�imler.
WO1999011256A8 (fr) L-threonate ferreux, composition pharmaceutique le contenant et son utilisation pour reduire et traiter l'anemie chez l'homme
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.
MXPA04004304A (es) Composicion farmaceutica que comprende polipeptidos del factor vii y polipeptidos del factor v.
GR1004016B (el) Αναβραζοντα δισκια, που περιεχουν ως δραστικο συστατικο συμπλοκες ενωσεις σιδηρου, για την θεραπεια των σιδηροπενικων αναιμιων
ES2188336A1 (es) Aductos de albumina soluble con complejos polihidroxilados (polialcoholicos) de hierro trivalente, metodo de obtencion y preparaciones farmaceuticas y dieteticas que los contienen.
DE60212424D1 (de) Radiopharmazeutishes mittel zur behandlung von krebs im frühstadium
HUP9700432A2 (hu) Magnéziumot és vitaminokat tartalmazó készítmények
WO2001071352A3 (en) Compositions associated with complex formation

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties